Biofrontera Inc. (BFRI)Healthcare | Drug Manufacturers - Specialty & Generic | Woburn, United States | NasdaqCM
1.59 USD
+0.10
(6.711%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.58 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:28 a.m. EDT
The short-term outlook remains neutral despite a recent price rebound, as the underlying business fundamentals are catastrophically broken. The company is generating significant free cash flow losses, has negative operating margins, and faces a massive debt burden relative to its equity. While the stock price has rallied recently, the annual trajectory reveals a brutal structural decline with three consecutive years of negative returns, culminating in a nearly 96% drop over the last three years. This multi-year collapse suggests the market has correctly identified a deteriorating asset, rendering any short-term technical bounce insufficient for a bullish entry. Furthermore, there is no dividend support whatsoever, offering zero income to offset the extreme capital risk. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.107478 |
| AutoETS | 0.114436 |
| AutoTheta | 0.118291 |
| AutoARIMA | 0.118515 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 6.62 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.601 |
| Excess Kurtosis | -0.59 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 125.991 |
| Revenue per Share | 3.923 |
| Market Cap | 23,615,252 |
| Forward P/E | 3.70 |
| Beta | 0.80 |
| Profit Margins | -13.79% |
| Website | https://www.biofrontera-us.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.77380955 |
| Address1 | 660 Main Street |
| Address2 | 1st Floor |
| All Time High | 292.6 |
| All Time Low | 0.536 |
| Ask | 1.94 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 687,860 |
| Average Daily Volume3 Month | 401,183 |
| Average Volume | 401,183 |
| Average Volume10Days | 687,860 |
| Beta | 0.798 |
| Bid | 1.14 |
| Bid Size | 2 |
| Book Value | 0.419 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.59 |
| Current Ratio | 1.18 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.61 |
| Day Low | 1.51 |
| Debt To Equity | 125.991 |
| Display Name | Biofrontera |
| Earnings Call Timestamp End | 1,786,629,600 |
| Earnings Call Timestamp Start | 1,786,629,600 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,794,400,200 |
| Earnings Timestamp Start | 1,794,400,200 |
| Ebitda | -5,968,000 |
| Ebitda Margins | -0.12925 |
| Enterprise To Ebitda | -4.432 |
| Enterprise To Revenue | 0.573 |
| Enterprise Value | 26,452,250 |
| Eps Current Year | -0.18 |
| Eps Forward | 0.43 |
| Eps Trailing Twelve Months | -0.46 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.17664 |
| Fifty Day Average Change | 0.41336 |
| Fifty Day Average Change Percent | 0.3513054 |
| Fifty Two Week Change Percent | 77.38096 |
| Fifty Two Week High | 1.61 |
| Fifty Two Week High Change | -0.01999998 |
| Fifty Two Week High Change Percent | -0.012422348 |
| Fifty Two Week Low | 0.555 |
| Fifty Two Week Low Change | 1.0350001 |
| Fifty Two Week Low Change Percent | 1.864865 |
| Fifty Two Week Range | 0.555 - 1.61 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,635,514,200,000 |
| Float Shares | 11,838,815 |
| Forward Eps | 0.43 |
| Forward P E | 3.6976745 |
| Free Cashflow | -7,597,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 84 |
| Fullday Change | 0.1 |
| Fullday Change Percent | 6.71141 |
| Fullday Price | 1.5802 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.79253 |
| Gross Profits | 36,595,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11993 |
| Held Percent Institutions | 0.20716 |
| Implied Shares Outstanding | 14,852,359 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-10-29 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,688,515,200 |
| Last Split Factor | 1:20 |
| Long Business Summary | Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. |
| Long Name | Biofrontera Inc. |
| Market | us_market |
| Market Cap | 23,615,252 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_531568773 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -6,365,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 22,130,014 |
| Number Of Analyst Opinions | 2 |
| Open | 1.53 |
| Operating Cashflow | -7,927,000 |
| Operating Margins | -0.04366 |
| Payout Ratio | 0.0 |
| Phone | 781 245 1325 |
| Post Market Change | -0.0098000765 |
| Post Market Change Percent | -0.61635697 |
| Post Market Price | 1.5802 |
| Post Market Time | 1,787,961,556 |
| Previous Close | 1.49 |
| Price Eps Current Year | -8.833333 |
| Price Hint | 4 |
| Price To Book | 3.7947495 |
| Price To Sales Trailing12 Months | 0.51142937 |
| Profit Margins | -0.13785 |
| Quick Ratio | 0.999 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.1 |
| Regular Market Change Percent | 6.71141 |
| Regular Market Day High | 1.61 |
| Regular Market Day Low | 1.51 |
| Regular Market Day Range | 1.51 - 1.61 |
| Regular Market Open | 1.53 |
| Regular Market Previous Close | 1.49 |
| Regular Market Price | 1.59 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 804,156 |
| Return On Assets | -0.1745 |
| Return On Equity | -9.88354 |
| Revenue Growth | 0.329 |
| Revenue Per Share | 3.923 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 14,852,359 |
| Shares Percent Shares Out | 0.0022 |
| Shares Short | 32,907 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 24,157 |
| Short Name | Biofrontera Inc. |
| Short Percent Of Float | 0.0023 |
| Short Ratio | 0.08 |
| Source Interval | 15 |
| State | MA |
| Symbol | BFRI |
| Target High Price | 9.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 6.0 |
| Target Median Price | 6.0 |
| Total Cash | 4,667,000 |
| Total Cash Per Share | 0.314 |
| Total Debt | 7,504,000 |
| Total Revenue | 46,175,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.46 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.96235 |
| Two Hundred Day Average Change | 0.62765 |
| Two Hundred Day Average Change Percent | 0.6522055 |
| Type Disp | Equity |
| Volume | 804,156 |
| Website | https://www.biofrontera-us.com |
| Zip | 1,801 |